Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction

(2020) Matteo Serenelli et al.   JACC-Heart Failure

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

(2019) Rolf Wachter et al.   EUROPEAN JOURNAL OF HEART FAILURE

Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

(2019) Michel Komajda et al.   EUROPEAN JOURNAL OF HEART FAILURE

Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial

(2019) Luis E Rohde et al.   EUROPEAN HEART JOURNAL

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

(2019) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF

(2019) Felipe A. Martinez et al.   CIRCULATION

Effect on Mortality of Higher vs Lower Beta Blocker (Metoprolol Succinate or Carvedilol) Dose in Patients with Heart Failure

(2018) Tarek Ajam et al.   AMERICAN JOURNAL OF CARDIOLOGY

Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril

(2018) Orly Vardeny et al.   Circulation-Heart Failure

Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study

(2018) A C Ruwald et al.   EUROPACE

Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey

(2018) Nicolas Girerd et al.   JACC-Heart Failure

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka

(2018) Ruth Webster et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure

(2018) Eric J. Velazquez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF

(2017) Michael Böhm et al.   EUROPEAN HEART JOURNAL

Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study

(2017) Michele Senni et al.   EUROPEAN JOURNAL OF HEART FAILURE

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

(2017) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF TrialCLINICAL PERSPECTIVE

(2016) Akshay S. Desai et al.   Circulation-Heart Failure

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial

(2016) Orly Vardeny et al.   EUROPEAN JOURNAL OF HEART FAILURE

Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens

(2016) Michele Senni et al.   EUROPEAN JOURNAL OF HEART FAILURE

Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey

(2016) Michel Komajda et al.   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF

(2016) Frank Edelmann et al.   JACC-Heart Failure

Addition of Ivabradine to β-Blocker Improves Exercise Capacity in Systolic Heart Failure Patients in a Prospective, Open-Label Study

(2015) A. E. Bagriy et al.   ADVANCES IN THERAPY

Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis

(2015) C. E. Jackson et al.   EUROPEAN HEART JOURNAL

Orthostatic Hypotension

(2015) Fabrizio Ricci et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact

(2013) John J. V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial

(2012) Andrew P. Ambrosy et al.   AMERICAN HEART JOURNAL

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

(2012) Stuart J. Pocock et al.   EUROPEAN HEART JOURNAL

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?

(2012) Karl Swedberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

(2010) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

(2009) Marvin A Konstam et al.   LANCET